Fundz

New Limit reported raising $130 Million in an initial SEC Form D filing, from an offering of $130 Million

PRIVATEMay 15, 2025$129.8M of $130M raised

Amount Raised

$130 Million

$130 Million sold, per SEC Form D (first sale May 2, 2025)

Round Type

Venture

South San FranciscoBiotechnology

Quick answer

NewLimit raised $130 Million in a funding round, dated May 2, 2025. NewLimit is based in South San Francisco, California, United States.

How much did NewLimit raise?
NewLimit raised $130 Million in a funding round on May 2, 2025.
What does NewLimit do?
NewLimit is a biotechnology company working to radically extend human healthspan.
Where is NewLimit based and how big is it?
NewLimit is based in South San Francisco, California, United States. Fundz records about 51 employees.
Who are the decision-makers at NewLimit?
Fundz holds 1 contact at NewLimit. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as NewLimit that raised within 45 days of this round, from Fundz verified event records.

  • Koios Care raised $1.2M (Seed) on June 16, 2025.
  • Membrion raised $11M on June 16, 2025.
  • EMVision raised $5M (Grant) on June 16, 2025.
  • Scope Biosciences raised $6.9M (Seed) on June 16, 2025.
  • PolyPid raised $27M on June 16, 2025.
  • Oxford Performance Materials raised $355K (Seed) on June 16, 2025.

Who to call at NewLimit, and when

A new round usually means NewLimit is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day NewLimit raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at NewLimit, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at NewLimit. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

NewLimit

Location

South San Francisco, California, United States

About

NewLimit is a biotechnology company working to radically extend human healthspan. We’re developing medicines to treat age-related diseases by reprogramming the epigenome, a new therapeutic mechanism to restore regenerative potential in aged and diseased cells. We leverage functional genomics, pooled perturbation screening, and machine learning models to unravel the biology of epigenetic aging and disease using experiments of unprecedented scale.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment NewLimit raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for NewLimit's next move

See what Strategic adds

NewLimit raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.